Stomach Cancer [clinicaltrials_resource:36cc6666c45fd4756da9f80a53f83922]
clinicaltrials:NCT00201747Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma [clinicaltrials:NCT00215462]Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma [clinicaltrials:NCT00215514]Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers [clinicaltrials:NCT00291473]clinicaltrials:NCT00296322clinicaltrials:NCT00296335A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women [clinicaltrials:NCT00342004]A Study of Vinflunine in Patients With Gastric Cancer [clinicaltrials:NCT00359476]Metastatic Gastric Cancer FFCD 03-07 [clinicaltrials:NCT00374036]Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer [clinicaltrials:NCT00394433]clinicaltrials:NCT00446290Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors [clinicaltrials:NCT00511576]clinicaltrials:NCT00525785Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy [clinicaltrials:NCT00622804]clinicaltrials:NCT00780494Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach [clinicaltrials:NCT00800969]clinicaltrials:NCT00857246clinicaltrials:NCT00858338Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer [clinicaltrials:NCT00911820]A Study With Health Educational Material on Health Promotion in Cancer Survivors [clinicaltrials:NCT00948337]Comparison of Standard of Care or Treatment on Protocol [clinicaltrials:NCT01010334]Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer [clinicaltrials:NCT01016639]clinicaltrials:NCT01038154Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma [clinicaltrials:NCT01048281]The Use of Ultrasonic Coagulating Shears Compared to Monopolar Electrocautery in Open Gastric Cancer Surgery [clinicaltrials:NCT01179750]clinicaltrials:NCT01236053clinicaltrials:NCT01246960clinicaltrials:NCT01257711Development of a Versatile Intra-operative On-screen Audiovisual Mentoring System Using TileproTM Program for Robotic Gastrectomy [clinicaltrials:NCT01319084]Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers [clinicaltrials:NCT01445327]Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients [clinicaltrials:NCT01618474]Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis [clinicaltrials:NCT01659619]Comparison of O-type Hybrid Knife and IT Knife in ESD [clinicaltrials:NCT01760070]A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach [clinicaltrials:NCT01774851]Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival [clinicaltrials:NCT02055313]Validation of MMS Test for Cancer Monitoring [clinicaltrials:NCT02113683]clinicaltrials:NCT02191566clinicaltrials:NCT02205463EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer [clinicaltrials:NCT02209415]clinicaltrials:NCT02216149
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Stomach Cancer [clinicaltrials_resource:36cc6666c45fd4756da9f80a53f83922]
Bio2RDF identifier
36cc6666c45fd4756da9f80a53f83922
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:36cc6666c45fd4756da9f80a53f83922
identifier
clinicaltrials_resource:36cc6666c45fd4756da9f80a53f83922
title
Stomach Cancer
@en
type
label
Stomach Cancer [clinicaltrials_resource:36cc6666c45fd4756da9f80a53f83922]
@en